Anti-infectious aerosols;Les anti-infectieux en aerosols

Revue des Maladies Respiratoires

Volumn 16, Issue 3, 1999, Pages 277-285

  Diot, P ^a   Dequin, P F ^b   Rivoire, B ^a   Gagnadoux, F ^a   Faurisson, F ^c   Diot, E ^a   Boissinot, E ^a   Lemarie E ^a  

^a Serv Pneumologie d'Explorations F   (France)

^b CHU BRETONNEAU   (France)

^c INSERM   (France)

Author keywords

Aerosols; Ani infectious drugs; Nebulizers

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPHOTERICIN B; ANTIINFECTIVE AGENT; BETA LACTAM ANTIBIOTIC; COLISTIN; PENTAMIDINE;

AEROSOL; ARTICLE; DOSIMETRY; DRUG STABILITY; MEDICAL NEBULIZER; NEBULIZATION; ULTRASOUND; HUMAN; NEBULIZER; RESPIRATORY TRACT INFECTION; REVIEW; STANDARD;

AEROSOLS; ANTI-BACTERIAL AGENTS; HUMANS; NEBULIZERS AND VAPORIZERS; RESPIRATORY TRACT INFECTIONS;

EID: 0032786426     PISSN: 07618425     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. BORACH AL, MOLOMUT M, SOROKA M : Inhalation of promin in experimental tuberculosis. Am Rev Tuberc 1942;46:268-76.
2. PASCAL S, DIOT P, LEMARIE E : Antibiothérapie en aérosols. Rev Mal Respir 1992;9:145-53.
3. TOUW DJ, BRIMICOMBE RW, HODSON ME, HEIJERMAN HGM, BAKKER W : Inhalation of antibiotics in cystic fibrosis. Eur Respir J 1995;8:1594-604.
4. MUKHOPADHYAY S, SINGH M, CATER JI, OGSTON S, FRANKLIN M, OLVER RE : Nebulised antipseudomonal antibiotic therapy in cystic fibrosis : a meta-analysis of benefits and risks. Thorax 1996;54:364-8.
5. BECQUEMIN MH, DIOT P : Optimisation des conditions d'aérosolisation de la pentamidine : études granulométriques et isotopiques. Med Mal Inf 1990;394-9.
6. NEWMAN SP, CLARKE SW : Aerosols in therapy. In Aerosols in Medicine. Principles, Diagnosis and Therapy. Moren, Newhouse, Dolovich eds. New York, Elsevier, 1985:312-89.
7. STAPLETON KW, FINLAY WH : Errors in characterizing nebulized particle size distributions with cascade impactors. J Aerosol Med 1998;11(suppl1):S80-S83.
8. CIPOLLA DC, CLARK AR, CHAN HK, GONDA I, SHIRE SJ : Assessment of aerosol delivery systems for recombinant human deoxyribonuclease. SJP Pharma Sciences 1994;4:50-62.
9. DIOT P, GAONADOUX F, MARTIN C et al. : Nebulization and anti-Pseudomonas aeruginosa activity of colistin. Eur Respir J 1997;10:1995-8.
10. DIOT P, LEMARIE E : Physiopathologic bases. In : Nuclear Medicine and lung diseases. Diot P, Baulieu JL, Lemarié E eds, Springer-Verlag, Paris, 1993:15-21.
11. HEYDER J : Mechanisms of aerosol particle deposition. Chest 1981;80:820-3.
12. Propositions de bonnes pratiques de l'aérosolthérapie par nébulisation. Rev Mal Respir 1997;14:512-6.
13. ® pour la production d'aérosols de colistine, tobramycine et amiloride. Rev Mal Respir 1994;11:573-8.
14. NIKANDER K : Drug delivery systems. J Aerosol Med 1994:7(suppl 1):S19-S24.
15. FAURISSON F, CONTREPOIS A, GROSSKOPF C : Aerosol inhalation before reading age. Lancet 1995;343:1298.
16. GAGNADOUX F, DIOT P, MARCHAND S et al. : Déposition pulmonaire des aérosols de colistine dans la mucoviscidose. Comparaison d'un nébuliseur ultrasonique et d'un nébuliseur pneumatique. Rev Mal Respir 1996;13:55-60.
17. DEQUIN PF, DELATOUR F, FAURISSON F et al. : Characterization on the bench of an amikacin aerosol before clinical studies. J Aerosol Med 1997;70:221-30.
18. DEQUIN PF, FAURISSON F, LEMARIE E et al. : Urinary excretion reflects lung deposition of amikacin aerosols in cystic fibrosis. Am J Respir Crit Care Med. Soumis.
19. ANSORG R, MULLER KD, WIORA J : Comparison of inhibitory and bactericidal activity of antipseudomonal antibiotics against Pseudomonas aeruginosa isolates from cystic fibrosis patients. Chemotherapy 1990;36:222-9.
20. DALLY M, KURRLE S, BRESLIN A : Ventilatory effects of aerosol gentamicin. Thorax 1978;33:54-6.
21. MELLIS CM, LEVISON H : Bronchial reactivity in cystic fibrosis. Pediatrics 1978;64:446-50.
22. WONNE R, HOFMANN D, POSSELT HG : Bronchial allergy in cystic fibrosis. Clin Allergy 1985;15:455-63.
23. MORROW PE : Aerosol characterization and deposition. Am Rev Respir Dis 1974;110:88-9.
24. SMALDONE GC, DIOT P, GROTH M, ILOWITE J : Respirable mass : vague and indefinable in disease. J Aerosol Med 1998;11(suppl 1):S105-S111.
25. NEWHOUSE MT : The current laboralory determination of « respirable mass »is not clinically relevant. J Aerosol Med 1998 ; 11(suppl 1):S122-S132.
26. EDMAN P : Pharmaceutical formulations. Suspensions and solutions. J Aerosol Med 1994;7(suppl 1):S3-S6.
27. DIOT P, RIVOIRE B, LE PAPE A et al. : Deposition of amphotericin B aerosols in pulmonary aspergilloma. Eur Respir J 1995;8:1263-8.
28. DIOT P, DEQUIN PF, DIOT E, LEMARIE E : Concepts pour l'évaluation de l'aérosolthérapie dans la mucoviscidose. In Les médicaments de la mucoviscidose chez l'enfant. Springer Paris, 1997:65-79.
29. SCHLESINGER RB : Comparative deposition of inhaled aerosols in experimental animals and humans : a review. J Toxicol Environ Health 1985;75:197-214.
30. ITOH H, ISHII Y, MAEDA H, TODO G, TORIZUKA K, SMALDONE GC : Clinical observations of aerosol deposition in patients with airway obstruction. Chest 1981;80:837-9.
31. STUART B, RICHLAND PD : Deposition of inhaled aerosols. Arch Intern Med 1973;131:60-72.
32. ALDERSON PO, SECKER-WALKER RH, STROMINGER DB, MARKHAM J, HILL RL : Pulmonary deposition of aerosols in children with cystic fibrosis. J Pediatr 1974;84:479-84.
33. MILLER WF : Aerosol therapy in acute and chronic respiratory disease. Arch Intern Med 1913;131:148-54.
34. SMALDONE GC, FUHRER J, STEIGBIGEL RT, Mc PECK M : Factors determining pulmonary deposition of aerosolized pentamidine in patients with human immunodeficiency virus infection. Am Rev Respir Dis 1991;143:727-37.
35. LITTLEWOOD JM, MILLER MG, GHONEIM AT, RAMSDEN CH : Nebulised colimycin for early psaeudomonas colonisation in cystic fibrosis. Lancet 1985;i:865.
36. ILOWITE JS, GORVOY JD, SMALDONE GC : Quantitative depositionof aerosolized gentamicin in cystic fibrosis. Am Rev Respir Dis 1981;136:1445-9.
37. DIOT P, PALMER LB, SMALDONE A et al. : RhDNase I aerosol deposition and related factors in cystic fibrosis. Am J Respir Crit Care Med 1997;156:1662-8.
38. ANDERSON PJ, WILSON JD, HILLER FC : Respiratory tract deposition of ultrafine particles in subjects with obstructive or restrictive lung disease. Chest 1990;97:1115-20.
39. Touw DJ, JACOBS FAH, BRIMICOMBE RW, HEUERMAN HGM, BAKKER W, BREIMER DD : Pharmacokinectics of aerosolized tobramycin in adult patients with cystic fibrosis. Antimicrob Agents Chemother 1997;41:184-7.
40. PALMER LB, SMALDONE GC, SIMON SR, O'RIORDAN TG, CUCCIA C : Aerosolized antibiotics in mechanically ventilated patients : delivery and response. Crit Care Med 1998 ;26 :31-9.